Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences.

Samoš M, Stančiaková L, Duraj L, Kovář F, Fedor M, Šimonová R, Bolek T, Galajda P, Staško J, Kubisz P, Mokáň M.

Medicine (Baltimore). 2017 Feb;96(6):e6045. doi: 10.1097/MD.0000000000006045.

2.
3.

Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study.

Santos RC, Goulart AC, Kisukuri AL, Brandão RM, Sitnik D, Staniak HL, Bittencourt MS, Lotufo PA, Bensenor IM, Santos IS.

Arq Bras Cardiol. 2016 Oct;107(4):323-330. Portuguese, English.

4.

Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk.

Elwood PC, Morgan G, Galante J, Chia JW, Dolwani S, Graziano JM, Kelson M, Lanas A, Longley M, Phillips CJ, Pickering J, Roberts SE, Soon SS, Steward W, Morris D, Weightman AL.

PLoS One. 2016 Nov 15;11(11):e0166166. doi: 10.1371/journal.pone.0166166. eCollection 2016.

5.

Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.

Yao Y, Zhang JH, Tang XF, He C, Ma YL, Xu JJ, Song Y, Liu R, Meng XM, Song L, Wang M, Gao RL, Yuan JQ.

Chin Med J (Engl). 2016 Oct 5;129(19):2269-74. doi: 10.4103/0366-6999.190664.

6.

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study.

Samoš M, Fedor M, Kovář F, Galajda P, Bolek T, Stančiaková L, Fedorová J, Staško J, Kubisz P, Mokáň M.

J Diabetes Res. 2016;2016:2909436. doi: 10.1155/2016/2909436. Epub 2016 Jul 17.

7.

Epidemiological Profile and Quality Indicators in Patients with Acute Coronary Syndrome in Northern Minas Gerais - Minas Telecardio 2 Project.

Marino BC, Marcolino MS, Reis Júnior Rdos S, França AL, Passos PF, Lemos TR, Antunes Ide O, Ferreira CG, Antunes AP, Ribeiro AL.

Arq Bras Cardiol. 2016 Aug;107(2):106-15. doi: 10.5935/abc.20160095. Epub 2016 Jun 23. English, Portuguese.

8.

Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.

Timmis A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, Moayyeri A, Stogiannis D, Shah AD, Pasea L, Denaxas S, Emmas C, Hemingway H.

BMJ. 2016 Jun 22;353:i3163. doi: 10.1136/bmj.i3163.

9.

Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.

Weiss TW, Aichinger J, Huber K, Speidl WS, Watzinger N, Zweiker R, Alber HF.

Wien Klin Wochenschr. 2016 Jun;128(11-12):450-7. doi: 10.1007/s00508-016-1016-7. Epub 2016 Jun 9. Review.

10.

Risks and Benefits of Dual Antiplatelet Therapy Beyond 12 Months After Coronary Stenting: A Prospective Randomized Cohort Study.

Dadjou Y, Safavi S, Kojuri J.

Medicine (Baltimore). 2016 May;95(22):e3663. doi: 10.1097/MD.0000000000003663.

11.

Association of Guideline-Based Admission Treatments and Life Expectancy After Myocardial Infarction in Elderly Medicare Beneficiaries.

Bucholz EM, Butala NM, Normand SL, Wang Y, Krumholz HM.

J Am Coll Cardiol. 2016 May 24;67(20):2378-91. doi: 10.1016/j.jacc.2016.03.507.

13.

Management of acute perioperative myocardial infarction: a case report of concomitant acute myocardial infarction and tumor bleeding in the transverse colon.

Li YF, Gao WQ, Li YX, Feng QZ, Zhu P.

Clin Interv Aging. 2016 Feb 18;11:159-66. doi: 10.2147/CIA.S91918. eCollection 2016.

14.

Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction.

Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, Jimenez-Herrera M, Ravn-Fischer A.

Scand J Trauma Resusc Emerg Med. 2015 Dec 1;23:105. doi: 10.1186/s13049-015-0188-x.

15.

It Is Not Mandatory to Use Triple Rather Than Dual Anti-Platelet Therapy After a Percutaneous Coronary Intervention With a Second-Generation Drug-Eluting Stent.

Kim JY, Choi YS, Kwon A, Chung WB, Park CS, Kim HY, Chang K, Lee MY, Chung WS, Seung KB.

Medicine (Baltimore). 2015 Nov;94(46):e2062. doi: 10.1097/MD.0000000000002062.

16.

Management of acute coronary syndromes in a developing country; time for a paradigm shift? an observational study.

Medagama A, Bandara R, De Silva C, Galgomuwa MP.

BMC Cardiovasc Disord. 2015 Oct 24;15:133. doi: 10.1186/s12872-015-0125-y.

18.

Bare-metal stent thrombosis two decades after stenting.

Acibuca A, Gerede DM, Vurgun VK.

Cardiovasc J Afr. 2015 Jul 23;26(4):e19-21. doi: 10.5830/CVJA-2015-034.

19.
20.

Age- and Gender-related Disparities in Primary Percutaneous Coronary Interventions for Acute ST-segment elevation Myocardial Infarction.

Pilgrim T, Heg D, Tal K, Erne P, Radovanovic D, Windecker S, Jüni P; AMIS Plus Investigators.

PLoS One. 2015 Sep 9;10(9):e0137047. doi: 10.1371/journal.pone.0137047. eCollection 2015.

Supplemental Content

Loading ...
Support Center